Covered recipient · General Payments record
BRAYDEN R FORBES
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2020–2024
$1,230.00
- Reported across 74 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $732.39 | 53 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $254.01 | 29 |
| UCB, Inc. | $58.79 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $55.13 | 2 |
| E.R. Squibb & Sons, L.L.C. | $50.38 | 3 |
| Lilly USA, LLC | $44.46 | 2 |
| Janssen Biotech, Inc. | $41.06 | 2 |
| Organon LLC | $36.81 | 3 |
| Galderma Laboratories, L.P. | $36.72 | 2 |
| Incyte Corporation | $29.26 | 2 |
| LEO Pharma Inc. | $28.50 | 1 |
| Amgen Inc. | $23.99 | 1 |
| PFIZER INC. | $21.09 | 1 |
| GENZYME CORPORATION | $21.00 | 1 |
| Corcept Therapeutics | $16.32 | 1 |
| Janssen Pharmaceuticals, Inc | $14.87 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (53)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202020222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $5.97 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741825 | CMS |
| ABBVIE INC. | $4.65 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741827 | CMS |
| ABBVIE INC. | $1.90 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741829 | CMS |
| ABBVIE INC. | $8.66 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741831 | CMS |
| ABBVIE INC. | $1.36 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741833 | CMS |
| ABBVIE INC. | $4.24 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741835 | CMS |
| ABBVIE INC. | $5.37 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741837 | CMS |
| ABBVIE INC. | $23.26 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741839 | CMS |
| ABBVIE INC. | $6.95 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741841 | CMS |
| ABBVIE INC. | $4.59 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741843 | CMS |
| ABBVIE INC. | $6.47 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741845 | CMS |
| ABBVIE INC. | $5.39 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741847 | CMS |
| ABBVIE INC. | $1.93 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741849 | CMS |
| ABBVIE INC. | $21.25 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741851 | CMS |
| ABBVIE INC. | $6.46 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741853 | CMS |
| ABBVIE INC. | $6.02 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741855 | CMS |
| ABBVIE INC. | $27.53 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741857 | CMS |
| ABBVIE INC. | $0.37 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741859 | CMS |
| ABBVIE INC. | $12.13 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741861 | CMS |
| ABBVIE INC. | $9.81 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741863 | CMS |
| ABBVIE INC. | $9.83 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741865 | CMS |
| ABBVIE INC. | $23.15 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741867 | CMS |
| ABBVIE INC. | $8.30 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741869 | CMS |
| ABBVIE INC. | $8.18 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741871 | CMS |
| ABBVIE INC. | $2.45 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741873 | CMS |
| ABBVIE INC. | $25.04 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741875 | CMS |
| ABBVIE INC. | $1.47 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741877 | CMS |
| ABBVIE INC. | $5.75 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741879 | CMS |
| ABBVIE INC. | $5.53 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103741881 | CMS |
| Amgen Inc. | $23.99 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117252642 | CMS |
| Corcept Therapeutics | $16.32 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117792042 | CMS |
| E.R. Squibb & Sons, L.L.C. | $17.09 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101794934 | CMS |
| E.R. Squibb & Sons, L.L.C. | $18.78 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101794949 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.51 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101794963 | CMS |
| Galderma Laboratories, L.P. | $14.60 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145297594 | CMS |
| Galderma Laboratories, L.P. | $22.12 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145297596 | CMS |
| GENZYME CORPORATION | $21.00 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139947717 | CMS |
| Incyte Corporation | $14.89 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141209469 | CMS |
| Incyte Corporation | $14.37 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141211607 | CMS |
| Janssen Biotech, Inc. | $19.27 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078782866 | CMS |
| Janssen Biotech, Inc. | $21.79 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078783009 | CMS |
| Janssen Pharmaceuticals, Inc | $14.87 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078219111 | CMS |
| LEO Pharma Inc. | $28.50 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152630047 | CMS |
| Lilly USA, LLC | $17.30 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136070241 | CMS |
| Lilly USA, LLC | $27.16 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136086302 | CMS |
| Novartis Pharmaceuticals Corporation | $21.67 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086944505 | CMS |
| Novartis Pharmaceuticals Corporation | $33.46 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086944503 | CMS |
| Organon Llc | $16.29 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136228606 | CMS |
| Organon Llc | $19.07 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136228610 | CMS |
| Organon Llc | $1.45 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136228614 | CMS |
| PFIZER INC. | $21.09 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131440929 | CMS |
| UCB, Inc. | $28.54 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143224924 | CMS |
| UCB, Inc. | $30.25 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143224928 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.